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Abstract
Background: The purpose of this study was to investigate current patterns of management and outcomes of
intermittent distance exotropia [X(T)] in the UK.
Methods: This was an observational cohort study which recruited 460 children aged < 12 years with previously
untreated X(T). Eligible subjects were enrolled from 26 UK hospital ophthalmology clinics between May 2005 and
December 2006. Over a 2-year period of follow-up, clinical data were prospectively recorded at standard intervals
from enrolment. Data collected included angle, near stereoacuity, visual acuity, control of X(T) measured with the
Newcastle Control Score (NCS), and treatment. The main outcome measures were change in clinical outcomes
(angle, stereoacuity, visual acuity and NCS) in treated and untreated X(T), 2 years from enrolment (or, where
applicable, 6 months after surgery). Change over time was tested using the chi-square test for categorical,
Wilcoxon test for non-parametric and paired-samples t-test for parametric data.
Results: At follow-up, data were available for 371 children (81% of the original cohort). Of these: 53% (195) had no
treatment; 17% (63) had treatment for reduced visual acuity only (pure refractive error and amblyopia); 13% (50)
had non surgical treatment for control (spectacle lenses, occlusion, prisms, exercises) and 17% (63) had surgery.
Only 0.5% (2/371) children developed constant exotropia. The surgically treated group was the only group with
clinically significant improvements in angle or NCS. However, 8% (5) of those treated surgically required second
procedures for overcorrection within 6 months of the initial procedure and at 6-month follow-up 21% (13) were
overcorrected.
Conclusions: Many children in the UK with X(T) receive active monitoring only. Deterioration to constant
exotropia, with or without treatment, is rare. Surgery appears effective in improving angle of X(T) and NCS, but
rates of overcorrection are high.
Background
Intermittent distance exotropia [X(T)] is a form of early
onset childhood strabismus, affecting around 32 per
100,000 of children aged under 19 years [1]. It com-
prises periodic divergent misalignment [2,3] which is
initially present on distance fixation, or during periods
of tiredness or inattention alone, but may become more
frequent and be present on near fixation, eventually
leading to constant exotropia in some cases. Constant
exotropia following de-compensation of intermittent to
constant exotropia causes loss of near stereopsis, with
suppression or panoramic vision and amblyopia, or
diplopia, depending on age of onset.
The frequency with which X(T) deteriorates to con-
stant exotropia is unclear, with some reports suggesting
a high frequency and advocating early intervention [4,5],
while others describe stability of X(T) over time in
many patients [6-8].
Surgical treatment is performed to prevent deteriora-
tion to constant exotropia, to improve distance stereoa-
cuity [9], and for aesthetic considerations. However it is
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known that surgical correction can result in overcorrec-
tion, causing constant esotropia, with potentially greater
functional and clinical consequences than the original X
(T) [10]. There is a lack of consensus on the appropriate
timing of surgical treatment [11-15] which balances the
risks of developing constant exotropia against those of
persistent post-operative overcorrection.
In the absence of robust evidence to guide manage-
ment it is difficult for clinicians to offer clear advice to
the parents of children with X(T) [16,17]. The objective
of this study was to investigate the current patterns of
management and outcomes of X(T) in the UK.
Methods
Participants
Children under the age of 12 years, diagnosed with X(T)
(of the true and simulated divergence excess and basic
types) within the preceding 12 months and previously
untreated, were eligible for the study. The minimum dis-
tance angle for inclusion was 10 prism diopters (PD). Chil-
dren with convergence insufficiency type of intermittent
exotropia (near deviation at least 10 PD more than dis-
tance deviation), constant exotropia, or significant coexist-
ing ocular pathology such as cataract, were not eligible.
Enrolment
Between May 2005 and December 2006 in 26 participat-
ing UK centres (see additional file 1: Collaborating cen-
tres), written informed consent was obtained from the
parents/guardians of patients participating in this study.
Details of the cohort and data collection procedures
have been reported elsewhere [18].
Procedure
No criteria were set regarding management decisions.
Rather, treatment regimes were at the discretion of the
local ophthalmologist/orthoptist, reflecting current prac-
tice in collaborating centres.
After piloting, a standardised assessment protocol [19]
was followed in each centre which comprised ophthal-
mic examination at enrolment and orthoptic assess-
ments at 3-monthly intervals within the first 12 months,
and 6-monthly thereafter. A standardised clinical history
was taken for all subjects, which included details of
pregnancy, birth, general and ocular health, estimated
age of onset, and family history of strabismus. Examina-
tion findings recorded included LogMAR visual acuity;
total near and distance angle of strabismus using the
alternate prism cover test and near stereoacuity using
the Frisby Near Stereoacuity Test (FNS™). Control of
the strabismus was assessed using the revised Newcastle
Control Score (NCS) [20] which combines an estimate
of observed frequency of the strabismus by parents/
carers (home control) with an assessment of the child’s
ability to realign the eyes following a cover test to
induce misalignment (clinic control), and is based on
previously published recommendations for surgical
treatment [4]. Possible NCS scores range from 0 to 9 (0
to 3 home control, 0 to 6 clinic control), with higher
scores indicative of a worse control. While clinic control
of X(T) may be unstable over short time periods [21],
the parent reported element (home control) of the New-
castle Control Score does ensure that the parent’s per-
spective is also taken into account: this is important in
an era of patient-centred health care and outcomes and
the pursuit of patient satisfaction.
Treatment was recorded as: observation only; treat-
ment for reduced visual acuity only (pure refractive
error and amblyopia); non-surgical treatment for control
of X(T) (spectacle lenses, exercises, prisms, alternate day
occlusion) and surgery for X(T).
Measurement outcomes
All measurements were attempted for all participants
within the constraints of age, cooperation and clinic
time. Within this report near stereo data are reported
only on participants aged 4 years or older because
younger participants were unable to consistently com-
plete testing. Distance stereoacuity testing was only pos-
sible in a limited number of centres, and is not reported.
For cases who received only observation or non-surgical
interventions, the outcome measures reported here are
those obtained at 24 months following enrolment (with a
time window of ± 3 months). In cases where surgery was
performed within 24 months following enrolment, the
outcome measures reported here are those obtained at 6
months post-surgery (time window ± 3 months): this was
considered the most suitable time point for assessment of
outcomes within the time constraints of the study.
Measurements of the amount of change in angle and
NCS excluded participants who had a persistent post-
surgical overcorrection (NCS is not measurable in the
presence of esotropia). Overcorrection was defined as
the presence of a manifest esotropia (any amount) at 1/
3 meter, 6 meters or both at 6 months post-surgery.
Constant exotropia was defined as a NCS clinic score
of 6: 3 for near clinic control (constant exotropia at
near), and 3 for distance clinic control (constant exotro-
pia at distance), with absent stereoacuity where it was
possible to test this. In children too young to perform
stereoacuity testing, the absence of binocular function-
ing was determined by the absence of motor fusion as
indicated by the use of prisms.
Analysis and Statistical Methods
As treatments were not mutually exclusive, for the pur-
poses of analysis participants who had treatment to both
improve acuity and strabismus were classified as having
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had treatment for strabismus, and those participants
who had non-surgical treatment prior to strabismus sur-
gery were classified in the surgery group. Thus out-
comes were compared by treatment group (observation,
treatment for vision only, non-surgical treatment only
for strabismus, surgical treatment for strabismus). Mean
total NCS, home control and clinic control component
scores were analysed. In terms of change in total NCS,
we deemed a change of 3 or more to constitute dete-
rioration or improvement in NCS control.
Change over time within groups was tested using the
chi-square test for categorical, Wilcoxon test for non-
parametric and paired-samples t-test for parametric data.
Stereo data was transformed into log seconds of arc, with
the few participants unable to respond to the highest
level (400 seconds of arc) allocated a score at the next
highest log level i.e. 2.90 log seconds of arc [22]. Change
was then calculated on a linear scale for each individual
and the change over time summarised for each group
(median logsec and interquartile range (IQR)) and tested
against the null hypothesis of no change.
Data were entered into a Microsoft Access database
and analyzed using SPSS for Windows Version 11. The
study was approved by the UK North West Multi-Cen-
tre Research Ethics Committee. Each collaborating cen-
tre obtained local approval from their relevant NHS
Trust R&D (Research and Development) Department.
The study was conducted in accordance with the tenets
of the Declaration of Helsinki.
Results
2 year follow-up data was available for 371/460 (81%) of
participants, without significant differences in NCS and
age at enrolment or treatment within 2 years, between
those included and those lost to follow-up (Figure 1).
Of the 371 participants in the study, 195 (53%) had no
treatment within two years, 63 (17%) had treatment for
reduced visual acuity only, 50 (13%) had non-surgical
treatment for X(T) whilst 63 (17%) participants had sur-
gery within two years of enrolment. Figure 1 provides a
breakdown of the types of treatment, and detail of parti-
cipation by treatment received within 2 years. Only 2
children (1 male, 1 female) had constant exotropia at 2
year follow-up. These children are included in the main
analysis. 13/63 (21%) of the surgical group had a persis-
tent overcorrection at 6 months post-surgery.
Newcastle Control Score (NCS)
The mean NCS at enrolment was higher (worse) in the
surgical group (4.98) compared to the observation
(3.43), vision only (3.38) and non-surgical treatment
(4.02) groups (Table 1). At follow-up the total mean
NCS in the surgery group was significantly reduced, on
average more than 60% in both the parental and clinic
component scores. There were significant but smaller
reductions in the total mean NCS at follow-up in the
non-surgical treatment and observation groups reflecting
an average 20% reduction in the clinical component and
13% reduction in the parental component respectively.
Changes in NCS from enrolment to follow-up are
shown by treatment group in Table 2. Overall in the
observation group, 19 (10%) improved, 163 (85%) stayed
stable and 9 (5%) deteriorated; in the non-surgical treat-
ment group 7 (15%) improved, 39 (81%) stayed stable
and 2 (4%) deteriorated; in the treatment for vision only
group, 5 (8%) improved, 53 (84%) stayed stable and 5
Figure 1 Participation by treatment, received within 2 years of diagnosis.
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(8%) deteriorated; in the surgery group 26/62 (42%)
improved, 21 (34%) stayed stable, 2 (3%) deteriorated
while 13 (21%) were overcorrected.
A score at final outcome of 0 (no detectable strabis-
mus) was found in 15/62 (24%) of the surgery group
plus a further 4/62 (6%) who received Botulinum toxin
to treat overcorrection within 6 months of surgery,
compared with 5/191 (2.5%) in the observation group,
1/48 (2%) in the non-surgical treatment group and 4/63
(6%) in the group treated only for reduced visual acuity.
There was no statistically significant difference in
overcorrection rates by type of surgery (7/27 (26%) in
the bilateral compared to 6/36 (17%) in the unilateral
group; Chi-Square test 0.80, p = 0.37). Of the 13 over-
corrections, mean [SD] total NCS, home control and
clinic control at enrolment were 5.08 [1.71], 2.08 [0.86]
and 3.0 [1.29] respectively (ranges 2 to 8, 1 to 3 and 1
to 6 respectively).
Changes in angle of X(T)
Table 3 provides details of near and distance angle. At
enrolment the median angle was 14 diopters for near
(range -6 to 50) and 25 diopters for distance (range 10 to
50) in the non-surgical groups and did not vary over
time. In the surgery group the median angle at enrolment
was 16 for near (range 1 to 45) and 30 for distance (range
20 to 60), and there were clinically significant changes at
follow-up: near angle was reduced from 16 to 7, and dis-
tance angle from 30 to 10 (Table 3).
Near Stereoacuity
212 participants were aged 4 years or older at enrol-
ment, of whom 166 (78%) attended follow-up. Log
transformed measures of near stereoacuity were avail-
able for 150/166 (90%) at both enrolment and outcome
(Table 4). There were significant improvements in the
observation and non-surgical treatment groups. The
surgery group overall also showed a similar level of
improvement although this was not statistically signifi-
cant. Of the 6 overcorrected children aged 4 or older at
enrolment, 5 (1 with prism) had some stereoacuity at
follow-up (with an abnormal head posture), and while
stereoacuity was absent in the other, his/her stereoacuity
at enrolment was unknown.
Visual Acuity
63/371 (17%) participants had treatment directed at
improving visual acuity only (i.e. refractive correction
and/or amblyopia treatment) within 2 years from enrol-
ment, including 26 participants who were observed at
enrolment and subsequently began treatment within 2
years of follow-up.
288/371 participants (78%) had LogMAR measures of
visual acuity in each eye at both enrolment and out-
come. There were small but statistically significant
improvements in mean acuity in the worse eye for all
groups apart from the surgical group, presumably
reflecting maturational changes in the observation group
(Table 5).
Discussion
From a multicentre study we report that only 17% of a
representative cohort of 371 children with X(T) were
treated surgically within 2 years of presentation. More
than half (53%) of the cohort were observed without any
treatment and 17% were treated for reduced acuity
rather than for strabismus. The proportion of children
who were simply observed is higher than would be
anticipated from some of the prior literature that advo-
cates early surgical treatment [4.5,11-13] possibly
reflecting international variations in practice. Our find-
ings suggest that observation without intervention is not
associated with deterioration in clinical outcomes in the
majority of children, in particular there appears to be an
Table 1 Change in mean and median total NCS by treatment group
Treatment within 2 years:
Total NCS
(0-9):
Observation
(n = 191)
Vision only
(n = 63)
Non-surgical
treatment
(n = 48)
Surgery
(n = 49)
Mean [SD]
median [IQR]
and (range) of NCS at enrolment
3.43 [1.44]
3 [2 to 4]
(1 to 8)
3.38 [1.53]
3 [2 to 4]
(1 to 7)
4.02 [1.47]
4 [3 to 5]
(1 to 9)
4.98 [1.94]
5 [3 to 6]
(2 to 9)
Mean [SD]
median [IQR]
and (range) of NCS at outcome
3.13 [1.65]
3 [2 to 4]
(0 to 9)
3.40 [1.89]
3 [2 to 4]
(0 to 7)
3.42 [2.01]
3 [2 to 4.75]
(0 to 8)
1.92 [2.19]
1 [0 to 3]
(0 to 9)
Mean difference[95% CIs] -0.30[-0.55 to
-0.05]
0.02[-0.41 to
0.44]
-0.60 [-1.15 to
-0.06]
-3.06[-3.83 to
-2.29]
Significance of difference between enrolment and 24 months/6-month post-
op, by treatment group
p = 0.021*
p = 0.028†
p = 0.94*
p = 0.98†
p = 0.031*
p = 0.026†
p < 0.001*
p < 0.001†
* paired samples t-test for differences in means
† Wilcoxon test for differences in medians
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extremely low conversion rate to constant exotropia
(0.5%) within the first 2 years after diagnosis. While this
finding is supported by studies which have found X(T)
to be a relatively stable condition in many cases [6-8] it
is possible that more children in our study may have
developed constant exotropia had they not received
treatment.
The children who underwent surgery had worse con-
trol at presentation, as measured by the Newcastle Con-
trol Score (which was expected as this is based on
criteria for surgical treatment). However they did not
have significantly greater angles of strabismus than
those who were treated non-surgically or simply
observed. While we cannot rule out potential bias in
comparing outcome at 6 months post-operatively with
24 month from enrolment in those not operated on,
surgery appeared the most effective intervention in
reducing the angle of X(T) and improving scores on the
NCS, albeit with a risk of overcorrection and, in one
case, absence of near stereoacuity.
Although prospective and involving a large number of
centres and with a reasonable sample size, (thus mini-
mising selection bias and role of chance), the observa-
tional nature of our study does not offer the same
possibility for comparing the effectiveness of different
treatment strategies as a randomised controlled trial.
Nevertheless, with standardised data collection and a
good level of completeness of follow-up, our study has
strengths in relation to understanding current manage-
ment practices in the UK and their effect on outcomes.
One reason for the low rates of surgery in our study
could have been concern about the possibility of persis-
tent post-operative overcorrection. 13/63 (21%) of the
patients undergoing surgery had persistent overcorrec-
tions at 6 months following surgery, including one who
had had a medial rectus injection of Botulinum toxin
between surgery and 6 months follow-up. A further 4
patients had persistent overcorrections treated success-
fully with either Botulinum toxin or surgery prior to the
6 month follow-up period. Ekdawi et al [23] reported
that 12 of 61 (19.7%) of their sample underwent a sec-
ond surgery, however in only 2 cases was this for conse-
cutive esotropia, the remainder of the second surgeries
being for recurrent exotropia. Likely explanations for
the high overcorrection rate in the present study include
the relatively short follow-up period, the more stringent
classification of an overcorrection and possible variation
in practice between individual surgeons.
Non-surgical treatment of X(T) had less significant
impact on angle of deviation or scores on the NCS, in
keeping with some prior reports [24,25], although
greater impact has been reported by others [26]. Whilst
no clinically significant changes were noted in angle of
deviation or on the NCS in children who were simply
observed, small statistically significant changes in near
stereoacuity and visual acuity were seen in this group
Table 2 Change in total Newcastle Control Score by treatment group
Treatment within 2 years:
Observation
n = 191
Vision only
n = 63
Non-surgical treatment
n = 48
Surgery
n = 62
Improved by ≥3; n (%) 19 (10) 5 (8) 7 (15) 26 (42)
Stable; n (%) 163 (85) 53 (84) 39 (81) 21 (34)
Deteriorated by ≥3; n (%) 9 (5) 5 (8) 2 (4) 2 (3)
Overcorrected n (%) - - - 13 (21)
The home control component score was missing for 1 patient at enrolment and outcome NCS were missing for one surgery and 5 non-surgery patients because
the home control component was not completed. (For the child who had surgery, no detectable squint was seen in the clinic.) Difference between groups in
proportions improved/stable/deteriorated: chi-square 58.9, p < 0.001.
Table 3 Change in near and distance angle by treatment group
Treatment within 2 years:
Observation Vision only Non-surgical treatment Surgery
Near APCT n = 171 n = 59 n = 46 n = 40†
Median [IQR] at enrolment 14[10 to 20] 14[10 to 20] 14[10 to 18] 16 [10 to 24]
Median [IQR] at outcome 14 [10 to 20] 14[8 to 20] 14 [10 to 20] 7 [2 to 12]
Median change [IQR] 0[-4 to 4] 0[-4 to 5] 0[-2 to 4] -9*[-18 to -1]
Distance APCT n = 169 n = 58 n = 46 n = 42†
Median [IQR] at enrolment 25 [20 to 35] 25[20 to 30] 25[20 to 32] 30[25 to 35]
Median [IQR] at outcome 25[19 to 30] 25[18 to 32] 25[18 to 30] 10[5 to 18]
Median change [IQR] 0[-7 to 5] 0[-6 to 5] 0[-5 to 0] -20*[-30 to -7]
†excludes overcorrections * p < 0.001 (Wilcoxon test)
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and serve to underline the importance of normal devel-
opmental changes in visual function that occur with age
which need to be accounted for in studies of natural
history and outcomes. We were unable to report dis-
tance stereoacuity and this is an important limitation of
the study.
The proportion of children receiving treatment for
reduced visual acuity (rather than strabismus) was sur-
prisingly large and almost all of these had refractive cor-
rection. A minority received patching in addition; most
children treated in this way had minor reductions in
acuity. Overall, no significant effects were observed in
median angle of X(T) or in NCS from treatment direc-
ted at improving visual acuity alone.
Conclusions
The findings of the present study highlight that: a) many
children with X(T) do not experience adverse outcomes
from observation or non-surgical treatment; b) the risk
of conversion from intermittent to constant exotropia is
minimal; c) a significant proportion of children who
undergo surgery for X(T) experience an overcorrection,
occasionally with loss of near stereoacuity.
Additional material
Additional file 1: The IOXT study collaborating centres. a list of the
26 collaborating centres.
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Table 4 Change in near stereoacuity (log transformed) by treatment group
Treatment within 2 years:
Observation
(n = 80)
Vision only
(n = 25)
Non-surgical
treatment
(n = 25)
Surgery
(n = 20)†
Median [IQR] logsec at enrolment 1.93 [1.74 to 2.04] 1.74 [1.74 to 2.08] 1.93[1.93 to 2.20] 1.93[1.74 to 2.14]
Median [IQR] logsec at outcome 1.74 [1.60 to 1.93] 1.74 [1.74 to 1.93] 1.74[1.60 to 1.90] 1.74[1.74 to 1.93]
Median change [IQR] in logsec -0.23 [-0.45 to 0.0] 0[-0.35 to 0.0] -0.33[-0.51 to 0.0] -0.09[-0.50 to 0.0]
Significance of difference between enrolment and 24 months/6-month
post-op by treatment group*
p < 0.001 p = 0.030 p < 0.001 p = 0.090
† Includes overcorrections * Wilcoxon test
Table 5 Change in visual acuity (worse eye) between enrolment and outcome, by treatment group
Treatment group:
Observation
(n = 156)
Vision only
(n = 45)
Non-surgical
treatment
(n = 40)
Surgery
(n = 36)
Mean [SD] acuity(worse eye) at enrolment (LogMAR) 0.127 [0.104] 0.211 [0.117] 0.169 [0.142] 0.178 [0.145]
Mean [SD] acuity(worse eye) at outcome (LogMAR) 0.081 [0.083] 0.141 [0.127] 0.107 [0.134] 0.144 [0.133]
Mean change[95% CIs] -0.045[-0.061 to -0.029] -0.069[-0.105 to -0.035] -0.062[-0.109 to -0.015] -0.034[-0.085 to 0.018]
Significance of difference between enrolment and
24 months/6-month post-op by treatment group*
p < 0.001 p < 0.001 p = 0.011 p = 0.195
*Paired samples t-test
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